Though, other reports have stated that TIM3 was positively correlated with overall survival in pancreatic ductal adenocarcinoma (Farren et al., 2016), and higher expression of TIM3 implicated in a worse 5‐year survival in renal cell carcinoma (Zheng et al., 2015). Here, HAVCR2 is linked to pancreatic ductal adenocarcinoma.